1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: Synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity

Add time:07/14/2019    Source:sciencedirect.com

A series of novel 1-(4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides were synthesized and confirmed with different spectroscopic techniques. The prepared compounds exhibited remarkable anti-inflammatory activity that represents 38%–100% of indomethacin activity and 44%–115% of celecoxib activity after 3 h. The anilides 5a–l and hydrazide 6 exhibit low incidence of gastric ulceration compared to indomethacin which was confirmed with histopathological investigation. In vitro COX-1/COX-2 inhibition studies showed compounds 4b (COX-1 IC50 = 45.9 μM; COX-2 IC50 = 68.2 μM) and 6 (COX-1 IC50 = 39.8 μM; COX-2 IC50 = 46.3 μM) are the most potent COX inhibitors in the tested compounds. The binding mode for some of the tested compounds to the enzymes was predicted using docking studies.

We also recommend Trading Suppliers and Manufacturers of 3-(2-chlorophenyl)-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-4(1H)-quinazolinone (cas 634173-85-6). Pls Click Website Link as below: cas 634173-85-6 suppliers

Prev:Aziridines derived from amino acids as synthons in pseudopeptide synthesis
Next:3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers)